FDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INO s REVEAL 1 Meets Goals finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Share:
HORSHAM, Pa., March 01, 2021 (GLOBE NEWSWIRE) STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced Robert (Bob) Moccia has been appointed President and Chief Executive Officer and a member of the board, effective March 1, 2021. Effective February 28, 2021, Dolev Rafaeli, Ph.D., stepped down as President and Chief Executive Officer and as a member of the board. We are delighted to welcome Bob to the STRATA team. He is a leader in the field of dermatology, and we are confident that his extensive executive management experience, spanning more than three decades in healthcare, predominantly in the dermatology sector, will deliver a seamless transition, said Uri Geiger, STRATA Skin Sciences Chairman. Looking forward, we believe his proven track record leading and building PE-backed dermatology growth companies, combined